Researchers gain new insights into how the isotope astatine-211 interacts with resins commonly used to purify the isotope for therapeutic use Targeted Alpha Therapy (TAT) is one of the most powerful ...
Radiopharmaceutical experts and researchers to gather June 19-20 in New Orleans NEW ORLEANS, May 12, 2025 (GLOBE NEWSWIRE) -- The first-ever U.S.-based meeting of the World Astatine Community will ...
Concept of the automated system for remote dissolution of the irradiated bismuth target and astatine recovery in nitric acid media. Astatine-211 (At-211) is one of a handful of promising alpha ...
Hosted on MSN
Targeted alpha therapy using astatine shows promise in thyroid cancer resistant to conventional treatment
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...
GOTHENBURG, Sweden and LONDON, Jan. 23, 2026 /PRNewswire/ -- Atley Solutions and Perceptive Discovery today announced the sale of two Atley C100 modules to Perceptive Discovery, marking the first step ...
DURHAM, NC, UNITED STATES, March 10, 2026 /EINPresswire.com/ — [DURHAM, NC, USA and JIAXING, CHINA] dGenThera, Inc. (“dGenThera”), a radiopharmaceutical company ...
Oncodesign Services, a preclinical CRO specialized in oncology, radiopharmaceuticals, and immune-mediated diseases, has extended its collaboration with GIP ARRONAX, a public research institute, to ...
Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF. Visit NAP.edu/10766 to get more information about this ...
dGenThera, Inc., a radiopharmaceutical company, announces partnership with Alpha Nuclide Co, LTD to secure scalable supply of Astatine-211 (At-211) in China. DURHAM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results